Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones

Malaria is still one of the most prevalent parasitic infections in the world, with half of the world’s population at risk for malaria. The effectiveness of current antimalarial therapies, even that of the most recent class of antimalarial drugs (artemisinin-combination therapies, ACTs), is under con...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2018-04, Vol.61 (8), p.3422-3435
Hauptverfasser: Bueno, José M, Calderon, Félix, Chicharro, Jesús, De la Rosa, Juan C, Díaz, Beatriz, Fernández, Jorge, Fiandor, José M, Fraile, María T, García, Mercedes, Herreros, Esperanza, García-Pérez, Adolfo, Lorenzo, Milagros, Mallo, Araceli, Puente, Margarita, Saadeddin, Anas, Ferrer, Santiago, Angulo-Barturen, Iñigo, Burrows, Jeremy N, León, María L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3435
container_issue 8
container_start_page 3422
container_title Journal of medicinal chemistry
container_volume 61
creator Bueno, José M
Calderon, Félix
Chicharro, Jesús
De la Rosa, Juan C
Díaz, Beatriz
Fernández, Jorge
Fiandor, José M
Fraile, María T
García, Mercedes
Herreros, Esperanza
García-Pérez, Adolfo
Lorenzo, Milagros
Mallo, Araceli
Puente, Margarita
Saadeddin, Anas
Ferrer, Santiago
Angulo-Barturen, Iñigo
Burrows, Jeremy N
León, María L
description Malaria is still one of the most prevalent parasitic infections in the world, with half of the world’s population at risk for malaria. The effectiveness of current antimalarial therapies, even that of the most recent class of antimalarial drugs (artemisinin-combination therapies, ACTs), is under continuous threat by the spread of resistant Plasmodium strains. As a consequence, there is still an urgent requirement for new antimalarial drugs. We previously reported the identification of 4­(1H)-pyridones as a novel series with potent antimalarial activities. The low solubility was identified as an issue to address. In this paper, we describe the synthesis and biological evaluation of 4­(1H)-pyridones with potent antimalarial activities in vitro and in vivo and improved pharmacokinetic profiles. Their main structural novelties are the presence of polar moieties, such as hydroxyl groups, and the replacement of the lipophilic phenyl rings with pyridines on their lipophilic side chains.
doi_str_mv 10.1021/acs.jmedchem.7b01256
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2019812461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2019812461</sourcerecordid><originalsourceid>FETCH-LOGICAL-a3756-54b3e5a3244044ad376e98f26763a2ddeda10d76803eac32277b977e59a301d43</originalsourceid><addsrcrecordid>eNp9kEtOwzAQhi0EgvK4AUJZwiJlPHbiZFkhXhICxGMdufFUNaRJsROk7HoFxA05CYa2LFmNNPP9M5qPsUMOQw7IT3Xphy8zMuWUZkM1Bo5JusEGPEGIZQZykw0AEGNMUeywXe9fAEBwFNtsB_Mky3OBA_b62NftlLz1ka5N9Ni6rmw7R1-Lz1HZ2nfb9tEDVbq1Te2ndu6jZhKFQHTbvFMVjerWznSlndWVj5Kvxcd976yxdV_F8phfnaw7TU1-n21NAkYHq7rHni_On86u4pu7y-uz0U2shUrSOJFjQYkWKCVIqY1QKeXZBFOVCo3GkNEcjEozEKRLgajUOFeKklwL4EaKPXa83Dt3zVtHvi1m1pdUVbqmpvMFAs8zjjLlAZVLtHSN944mxdyFh1xfcCh-NBdBc7HWXKw0h9jR6kI3DrO_0NprAGAJ_MabztXh4f93fgMZFI-L</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2019812461</pqid></control><display><type>article</type><title>Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones</title><source>ACS Publications</source><source>MEDLINE</source><creator>Bueno, José M ; Calderon, Félix ; Chicharro, Jesús ; De la Rosa, Juan C ; Díaz, Beatriz ; Fernández, Jorge ; Fiandor, José M ; Fraile, María T ; García, Mercedes ; Herreros, Esperanza ; García-Pérez, Adolfo ; Lorenzo, Milagros ; Mallo, Araceli ; Puente, Margarita ; Saadeddin, Anas ; Ferrer, Santiago ; Angulo-Barturen, Iñigo ; Burrows, Jeremy N ; León, María L</creator><creatorcontrib>Bueno, José M ; Calderon, Félix ; Chicharro, Jesús ; De la Rosa, Juan C ; Díaz, Beatriz ; Fernández, Jorge ; Fiandor, José M ; Fraile, María T ; García, Mercedes ; Herreros, Esperanza ; García-Pérez, Adolfo ; Lorenzo, Milagros ; Mallo, Araceli ; Puente, Margarita ; Saadeddin, Anas ; Ferrer, Santiago ; Angulo-Barturen, Iñigo ; Burrows, Jeremy N ; León, María L</creatorcontrib><description>Malaria is still one of the most prevalent parasitic infections in the world, with half of the world’s population at risk for malaria. The effectiveness of current antimalarial therapies, even that of the most recent class of antimalarial drugs (artemisinin-combination therapies, ACTs), is under continuous threat by the spread of resistant Plasmodium strains. As a consequence, there is still an urgent requirement for new antimalarial drugs. We previously reported the identification of 4­(1H)-pyridones as a novel series with potent antimalarial activities. The low solubility was identified as an issue to address. In this paper, we describe the synthesis and biological evaluation of 4­(1H)-pyridones with potent antimalarial activities in vitro and in vivo and improved pharmacokinetic profiles. Their main structural novelties are the presence of polar moieties, such as hydroxyl groups, and the replacement of the lipophilic phenyl rings with pyridines on their lipophilic side chains.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.7b01256</identifier><identifier>PMID: 29589932</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Antimalarials - chemical synthesis ; Antimalarials - chemistry ; Antimalarials - pharmacokinetics ; Antimalarials - pharmacology ; Female ; Mice ; Molecular Structure ; Parasitic Sensitivity Tests ; Plasmodium falciparum - drug effects ; Plasmodium yoelii - drug effects ; Pyridones - chemical synthesis ; Pyridones - chemistry ; Pyridones - pharmacokinetics ; Pyridones - pharmacology ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2018-04, Vol.61 (8), p.3422-3435</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a3756-54b3e5a3244044ad376e98f26763a2ddeda10d76803eac32277b977e59a301d43</citedby><cites>FETCH-LOGICAL-a3756-54b3e5a3244044ad376e98f26763a2ddeda10d76803eac32277b977e59a301d43</cites><orcidid>0000-0002-5411-0382 ; 0000-0003-0486-6883 ; 0000-0003-0498-9066</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b01256$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01256$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29589932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bueno, José M</creatorcontrib><creatorcontrib>Calderon, Félix</creatorcontrib><creatorcontrib>Chicharro, Jesús</creatorcontrib><creatorcontrib>De la Rosa, Juan C</creatorcontrib><creatorcontrib>Díaz, Beatriz</creatorcontrib><creatorcontrib>Fernández, Jorge</creatorcontrib><creatorcontrib>Fiandor, José M</creatorcontrib><creatorcontrib>Fraile, María T</creatorcontrib><creatorcontrib>García, Mercedes</creatorcontrib><creatorcontrib>Herreros, Esperanza</creatorcontrib><creatorcontrib>García-Pérez, Adolfo</creatorcontrib><creatorcontrib>Lorenzo, Milagros</creatorcontrib><creatorcontrib>Mallo, Araceli</creatorcontrib><creatorcontrib>Puente, Margarita</creatorcontrib><creatorcontrib>Saadeddin, Anas</creatorcontrib><creatorcontrib>Ferrer, Santiago</creatorcontrib><creatorcontrib>Angulo-Barturen, Iñigo</creatorcontrib><creatorcontrib>Burrows, Jeremy N</creatorcontrib><creatorcontrib>León, María L</creatorcontrib><title>Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Malaria is still one of the most prevalent parasitic infections in the world, with half of the world’s population at risk for malaria. The effectiveness of current antimalarial therapies, even that of the most recent class of antimalarial drugs (artemisinin-combination therapies, ACTs), is under continuous threat by the spread of resistant Plasmodium strains. As a consequence, there is still an urgent requirement for new antimalarial drugs. We previously reported the identification of 4­(1H)-pyridones as a novel series with potent antimalarial activities. The low solubility was identified as an issue to address. In this paper, we describe the synthesis and biological evaluation of 4­(1H)-pyridones with potent antimalarial activities in vitro and in vivo and improved pharmacokinetic profiles. Their main structural novelties are the presence of polar moieties, such as hydroxyl groups, and the replacement of the lipophilic phenyl rings with pyridines on their lipophilic side chains.</description><subject>Animals</subject><subject>Antimalarials - chemical synthesis</subject><subject>Antimalarials - chemistry</subject><subject>Antimalarials - pharmacokinetics</subject><subject>Antimalarials - pharmacology</subject><subject>Female</subject><subject>Mice</subject><subject>Molecular Structure</subject><subject>Parasitic Sensitivity Tests</subject><subject>Plasmodium falciparum - drug effects</subject><subject>Plasmodium yoelii - drug effects</subject><subject>Pyridones - chemical synthesis</subject><subject>Pyridones - chemistry</subject><subject>Pyridones - pharmacokinetics</subject><subject>Pyridones - pharmacology</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtOwzAQhi0EgvK4AUJZwiJlPHbiZFkhXhICxGMdufFUNaRJsROk7HoFxA05CYa2LFmNNPP9M5qPsUMOQw7IT3Xphy8zMuWUZkM1Bo5JusEGPEGIZQZykw0AEGNMUeywXe9fAEBwFNtsB_Mky3OBA_b62NftlLz1ka5N9Ni6rmw7R1-Lz1HZ2nfb9tEDVbq1Te2ndu6jZhKFQHTbvFMVjerWznSlndWVj5Kvxcd976yxdV_F8phfnaw7TU1-n21NAkYHq7rHni_On86u4pu7y-uz0U2shUrSOJFjQYkWKCVIqY1QKeXZBFOVCo3GkNEcjEozEKRLgajUOFeKklwL4EaKPXa83Dt3zVtHvi1m1pdUVbqmpvMFAs8zjjLlAZVLtHSN944mxdyFh1xfcCh-NBdBc7HWXKw0h9jR6kI3DrO_0NprAGAJ_MabztXh4f93fgMZFI-L</recordid><startdate>20180426</startdate><enddate>20180426</enddate><creator>Bueno, José M</creator><creator>Calderon, Félix</creator><creator>Chicharro, Jesús</creator><creator>De la Rosa, Juan C</creator><creator>Díaz, Beatriz</creator><creator>Fernández, Jorge</creator><creator>Fiandor, José M</creator><creator>Fraile, María T</creator><creator>García, Mercedes</creator><creator>Herreros, Esperanza</creator><creator>García-Pérez, Adolfo</creator><creator>Lorenzo, Milagros</creator><creator>Mallo, Araceli</creator><creator>Puente, Margarita</creator><creator>Saadeddin, Anas</creator><creator>Ferrer, Santiago</creator><creator>Angulo-Barturen, Iñigo</creator><creator>Burrows, Jeremy N</creator><creator>León, María L</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5411-0382</orcidid><orcidid>https://orcid.org/0000-0003-0486-6883</orcidid><orcidid>https://orcid.org/0000-0003-0498-9066</orcidid></search><sort><creationdate>20180426</creationdate><title>Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones</title><author>Bueno, José M ; Calderon, Félix ; Chicharro, Jesús ; De la Rosa, Juan C ; Díaz, Beatriz ; Fernández, Jorge ; Fiandor, José M ; Fraile, María T ; García, Mercedes ; Herreros, Esperanza ; García-Pérez, Adolfo ; Lorenzo, Milagros ; Mallo, Araceli ; Puente, Margarita ; Saadeddin, Anas ; Ferrer, Santiago ; Angulo-Barturen, Iñigo ; Burrows, Jeremy N ; León, María L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a3756-54b3e5a3244044ad376e98f26763a2ddeda10d76803eac32277b977e59a301d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Antimalarials - chemical synthesis</topic><topic>Antimalarials - chemistry</topic><topic>Antimalarials - pharmacokinetics</topic><topic>Antimalarials - pharmacology</topic><topic>Female</topic><topic>Mice</topic><topic>Molecular Structure</topic><topic>Parasitic Sensitivity Tests</topic><topic>Plasmodium falciparum - drug effects</topic><topic>Plasmodium yoelii - drug effects</topic><topic>Pyridones - chemical synthesis</topic><topic>Pyridones - chemistry</topic><topic>Pyridones - pharmacokinetics</topic><topic>Pyridones - pharmacology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bueno, José M</creatorcontrib><creatorcontrib>Calderon, Félix</creatorcontrib><creatorcontrib>Chicharro, Jesús</creatorcontrib><creatorcontrib>De la Rosa, Juan C</creatorcontrib><creatorcontrib>Díaz, Beatriz</creatorcontrib><creatorcontrib>Fernández, Jorge</creatorcontrib><creatorcontrib>Fiandor, José M</creatorcontrib><creatorcontrib>Fraile, María T</creatorcontrib><creatorcontrib>García, Mercedes</creatorcontrib><creatorcontrib>Herreros, Esperanza</creatorcontrib><creatorcontrib>García-Pérez, Adolfo</creatorcontrib><creatorcontrib>Lorenzo, Milagros</creatorcontrib><creatorcontrib>Mallo, Araceli</creatorcontrib><creatorcontrib>Puente, Margarita</creatorcontrib><creatorcontrib>Saadeddin, Anas</creatorcontrib><creatorcontrib>Ferrer, Santiago</creatorcontrib><creatorcontrib>Angulo-Barturen, Iñigo</creatorcontrib><creatorcontrib>Burrows, Jeremy N</creatorcontrib><creatorcontrib>León, María L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bueno, José M</au><au>Calderon, Félix</au><au>Chicharro, Jesús</au><au>De la Rosa, Juan C</au><au>Díaz, Beatriz</au><au>Fernández, Jorge</au><au>Fiandor, José M</au><au>Fraile, María T</au><au>García, Mercedes</au><au>Herreros, Esperanza</au><au>García-Pérez, Adolfo</au><au>Lorenzo, Milagros</au><au>Mallo, Araceli</au><au>Puente, Margarita</au><au>Saadeddin, Anas</au><au>Ferrer, Santiago</au><au>Angulo-Barturen, Iñigo</au><au>Burrows, Jeremy N</au><au>León, María L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2018-04-26</date><risdate>2018</risdate><volume>61</volume><issue>8</issue><spage>3422</spage><epage>3435</epage><pages>3422-3435</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Malaria is still one of the most prevalent parasitic infections in the world, with half of the world’s population at risk for malaria. The effectiveness of current antimalarial therapies, even that of the most recent class of antimalarial drugs (artemisinin-combination therapies, ACTs), is under continuous threat by the spread of resistant Plasmodium strains. As a consequence, there is still an urgent requirement for new antimalarial drugs. We previously reported the identification of 4­(1H)-pyridones as a novel series with potent antimalarial activities. The low solubility was identified as an issue to address. In this paper, we describe the synthesis and biological evaluation of 4­(1H)-pyridones with potent antimalarial activities in vitro and in vivo and improved pharmacokinetic profiles. Their main structural novelties are the presence of polar moieties, such as hydroxyl groups, and the replacement of the lipophilic phenyl rings with pyridines on their lipophilic side chains.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>29589932</pmid><doi>10.1021/acs.jmedchem.7b01256</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-5411-0382</orcidid><orcidid>https://orcid.org/0000-0003-0486-6883</orcidid><orcidid>https://orcid.org/0000-0003-0498-9066</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2018-04, Vol.61 (8), p.3422-3435
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_2019812461
source ACS Publications; MEDLINE
subjects Animals
Antimalarials - chemical synthesis
Antimalarials - chemistry
Antimalarials - pharmacokinetics
Antimalarials - pharmacology
Female
Mice
Molecular Structure
Parasitic Sensitivity Tests
Plasmodium falciparum - drug effects
Plasmodium yoelii - drug effects
Pyridones - chemical synthesis
Pyridones - chemistry
Pyridones - pharmacokinetics
Pyridones - pharmacology
Structure-Activity Relationship
title Synthesis and Structure–Activity Relationships of the Novel Antimalarials 5‑Pyridinyl-4(1H)‑Pyridones
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A24%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20Structure%E2%80%93Activity%20Relationships%20of%20the%20Novel%20Antimalarials%205%E2%80%91Pyridinyl-4(1H)%E2%80%91Pyridones&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Bueno,%20Jose%CC%81%20M&rft.date=2018-04-26&rft.volume=61&rft.issue=8&rft.spage=3422&rft.epage=3435&rft.pages=3422-3435&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.7b01256&rft_dat=%3Cproquest_cross%3E2019812461%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2019812461&rft_id=info:pmid/29589932&rfr_iscdi=true